Abstract
Reduced nitric oxide production is associated with pathological changes in the cardiovascular system. In a study of randomly chosen families, we analysed the relationship between two polymorphisms (Glu298Asp and intron 4) of the endothelial nitric oxide synthase (eNOS) and ambulatory blood pressure (ABP), left ventricular mass index (LVMI) and vascular phenotypes. The study population consisted of 127 parents and 167 offspring. All subjects underwent 24 h ABP monitoring using a SpaceLabs 90207 device. 2D and M-mode echocardiograms were obtained. Pulse wave velocity between the common carotid and femoral artery was measured with the Complior® device, and the carotid intima-media thickness (IMT) was assessed by ultrasound. For statistical analysis, covariables and correlations between relatives were taken into account. The frequency of genotypes was as follows: for Glu298Asp: 55.1%—Glu/Glu, 40.1%—Glu/Asp and 4.8%—Asp/Asp; for intron 4: 65.0%—4 b/b, 33.3%—4 b/a and 1.7%—4 a/a, being in Hardy–Weinberg equilibrium (P⩾0.29). There was no relationship between the eNOS gene polymorphisms and ABP or LVMI either in parents or their offspring. Among parents, carriers of the 298Asp allele had higher IMT values as compared with Glu/Glu homozygotes (0.94 vs 0.70 mm; P=0.007). Among offspring, there was a similar tendency (0.60 vs 0.53 mm; P=0.10), which was confirmed by transmission disequilibrium tests for quantitative variables (P⩾0.07). Our findings indicate that the Glu298Asp polymorphism of eNOS identifies patients with larger carotid IMT, also in younger subjects.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Moncada S, Higgs A . The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002–2012.
Duplain H, Burcelin R, Sartori C . Insulin resistance, hyperlipidaemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 2001; 104: 342–345.
Kuhlencordt PJ, Gyurko R, Han F . Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 2001; 104: 448–454.
Soubrier F . Nitric oxide synthase genes. Candidate genes among many others. Hypertension 1999; 33: 924–926.
Oemar BS et al. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 1998; 97: 2494–2498.
Vallance P, Collier J, Moncada S . Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2: 997–1000.
Huang PL et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377: 239–242.
Forte P et al. Basal nitric oxide synthesis in essential hypertension. Lancet 1997; 349: 837–842.
Taddei S et al. Defective L-arginine–nitric oxide pathway in offspring of essential hypertensive patients. Circulation 1996; 94: 1298–1303.
Cayatte A, Palacino JJ, Horten K, Cohen RA . Chronic inhibition of nitric oxide production accelerates neo-intima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb 1994; 14: 753–759.
Tesauro M et al. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary disease: cleavage of proteins with aspartate vs glutamate at position 298. Proc Natl Acad Sci USA 2000; 97: 2832–2835.
Tsukada T et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Com 1998; 245: 190–193.
Wang XL et al. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996; 2: 41–45.
Kuznetsova T et al. Quality control of the blood pressure phenotype in the European Project on Genes in Hypertension. Blood Pressure Monit 2002; 7: 215–224.
Staessen JA, Fagard R, Amery A . Life style as a determinant of blood pressure in the general population. Am J Hypertens 1994; 7: 685–694.
41st World Medical Assembly. Declaration of Helsinki: recommendations guiding physicians in biomedical research involving human subjects. Bull Pan Am Health Organ 1990; 24: 606–609.
van Ittersum FJ, IJzerman RG, Stehouwer CDA, Donker AJM . Analysis of twenty-four-hour ambulatory blood pressure monitoring: what time period to assess blood pressure during waking and sleeping. J Hypertens 1995; 13: 1053–1058.
Sahn DJ, DeMaria A, Kisslo J, Weyman A . Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–1083.
Schiller NB et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 1989; 2: 358–367.
Devereux RB et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450–458.
Wendelhag I, Wiklund O, Wikstrand J . Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia. Ultrasonographic assessement of intima-media thickness and plaque occurence. Arterioscler Thromb 1993; 13: 1404–1411.
Wang XL et al. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996; 2: 41–45.
Shimasaki Y et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 1998; 31: 1506–1510.
The SAS Institute. The GENMOD Procedure, SAS Online Doc Version 7.1: SAS/STAT. The SAS Institute Inc.: Cary, NC, 2000, pp 1311–1411.
Abecasis GR, Cardon LR, Cookson WOC . A general test of association for quantitative traits in nuclear families. Am J Hum Genet 2000; 66: 279–292.
Abecasis GR, Cookson WOC, Cardon LR . Pedigree tests of transmission disequilibrium. Eur J Hum Genet 2000; 8: 545–551.
Allison DB . Transmission-disequilibrium test for quantitative traits. Am J Hum Genet 1997; 60: 676–690.
Waldman ID, Robinson BF, Rowe DC . A logistic regression based extension of the TDT for continuous and categorical traits. Ann Hum Genet 1999; 63: 329–340.
Ross R . The pathogenesis of atherosclerosis: a perspective for the 1990 s. Nature 1993; 362: 801–809.
Ross R . Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115–126.
Cooke JP . Role of nitric oxide in progression and regression of atherosclerosis. West J Med 1996; 164: 419–424.
Philip I et al. G894 T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenilephrine. Circulation 1999; 99: 3096–3098.
Leeson CPM et al. Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function. Circ Res 2002; 90: 1153–1158.
Guzik TJ, Black E, West NE . Relationship between the G894T polymorphism (Glu298Asp variant) in endothelial nitric oxide synthase and nitric-oxide mediated endothelial function in human atherosclerosis. Am J Med Genet 2001; 100: 130–137.
Bots ML et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction. Circulation 1997; 96: 1432–1437.
Hodis HN et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998; 128: 262–269.
Lembo G et al. A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis. Stroke 2001; 32: 735–740.
Karvonen J et al. Endothelial nitric oxide synthase gene Glu298Asp polymorphisms and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med 2002; 251: 102–110.
Schmoelzer I et al. Lack of association of the Glu298Asp polymorphism of endothelial nitric oxide synthase with manifest coronary artery disease, carotid atherosclerosis and forearm vascular reactivity in two Austrian populations. Eur J Clin Invest 2003; 33: 191–198.
Markus HS, Ruigrok Y, Ali N, Powell JF . Endothelial nitric oxide synthase exon 7 polymorphism and ischaemic cerebrovascular disease and carotid atheroma. Stroke 1998; 32: 735–740.
Rudic RD et al. Direct evidence for the importance of endothelial-derived nitric oxide in vascular remodeling. J Clin Invest 1998; 101: 731–736.
Asakimori Y, Yorioka N, Tanaka J, Kohno N . Effect of polymorphism of the endothelial nitric oxide synthase and apolipoprotein E genes on carotid atherosclerosis in hemodialysis patients. Am J Kidney Dis 2003; 41: 822–832.
Lacolley P et al. Nitric oxide synthase gene polymorphisms, blood pressure and aortic stiffness in normotensive and hypertensive subjects. J Hypertens 1998; 16: 31–35.
Tsujita Y et al. Association analyses between genetic polymorphisms of endothelial nitric oxide synthase gene and hypertension in Japanese: The Suita Study. J Hypertens 2001; 19: 1941–1948.
Karvonen J et al. Endothelial nitric oxide synthase gene Glu298Asp polymorphisms and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med 2002; 251: 102–110.
Benjafield AV, Morris BJ . Association analyses of endothelial nitric oxide synthase gene polymorphisms in essential hypertension. Am J Hypertens 2000; 13: 994–998.
Pulkkinen A et al. Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with elevated blood pressure in type 2 diabetic patients with coronary heart disease. J Mol Med 2000; 78: 372–379.
Morita T et al. Effect of polymorphism of endothelial nitric oxide synthase gene in Japanese patients with IgA nephropathy. Clin Nephrol 1999; 52: 203–209.
Uwabo J, Soma M, Nakayama T, Kanmatsuse K . Association of a variable number of tandem repeats in the endothelial nitric oxide synthase gene with essential hypertension in Japanese. Am J Hypertens 1998; 11: 125–128.
Takaoka M et al. Association of the missense Glu298Asp variant of the eNOS gene with left ventricular hypertrophy and carotid atherosclerosis in patients with essential hypertension. Atherosclerosis 2001; 2: 42–43.
Acknowledgements
Nuclear families were recruited for the European Project on Genes in Hypertension, supported by the European Union (contract no. IC15-CT98-0329-EPOGH). The present study was supported by a grant from the State Committee for Research (Warsaw, Poland), Grant No. 6PO5B 134 21.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Czarnecka, D., Kawecka-Jaszcz, K., Stolarz, K. et al. Ambulatory blood pressure, left ventricular mass and vascular phenotypes in relation to the endothelial nitric oxide synthase gene Glu298Asp and intron 4 polymorphisms in a population-based family study. J Hum Hypertens 19, 413–420 (2005). https://doi.org/10.1038/sj.jhh.1001837
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001837
Keywords
This article is cited by
-
Associations of the eNOS G894T gene polymorphism with target organ damage in children with newly diagnosed primary hypertension
Pediatric Nephrology (2015)
-
Hypertension and genes: perspectives from this journal
Journal of Human Hypertension (2007)
-
Towards understanding the aetiology and pathophysiology of human hypertension: where are we now?
Journal of Human Hypertension (2006)
-
Insights into human hypertension: the role of endothelial dysfunction
Journal of Human Hypertension (2006)